PATHOGENESIS MOST ACEPTED THEORY --- AUTO DIGESTION PHASES 1. Enzyme Autoactivation 2.Chemoattraction & sequestration ofPMN and macrophages releasing CK 3. Local & Systemic effects
TRYPSIN Other Proenzyme activation Autoactivation Prophospholipase Pro elastase prekallikrein Phospholipase elastase kallikrein Fat necrosis weakens BV clotting . cascade HEMORRHAGE
GLASGOW SCALE On admission With in 48 hrs WBC > 15,000 cells/ cumm Age > 55yrs Glucose > 200 mg/dl Arterial Po2 <60 mmHg Urea >45 mg/dl S.Calcium <8mg/dl S.Albumin <3.2mg/dl S.LDH >600U/L S.ALT > 200 U/L
APACHE – II scoring system 12 point scoring system After 24 hrs of admission into ICU
CTSI Includes BALTHAZAR SCORE & NECROSIS SCORE
BALTHAZAR SCORE GRADE --- DESCRIPTION --- SCORE A Normal pancreas B Enlarged pancreas 1 C Inflammatorychanges 2 in pancreas and peri pancreatic fat D Ill defined single 3 peripancreatic fluid collection E ≥2 Ill defined fluid collections 4
HAPS (Harmless Acute Pancreatitis Score) High PPV Used to predict a milder course of illness Includes 1.Guarding &/ Rebound tenderness +/- 2.Creatinine <2mg/dl 3.Hematocrit < 43%(M) <39.6%(F) Score of “0” good prognosis
ATLANTA CLASSIFICATION MILD : no local complications & organ failure MODERATELY SEVERE : transient organ failure <48hrs +/- local complications SEVERE : persistent organ failure (>48hrs) with local and systemic complications
GRADING OF SEVERITY OF ATTACK BISAP score of 3 - 5 Ransons ’ score ≥ 3 Glassgow score ≥ 3 APACHE II score ≥ 8 CTSI (Balthazar) ≥ 6 Modified CTSI score of 8-10 Persistent organ failure( RevisedAtlanta ) CRP >150mg/dl
Lab parameters………. *CBP * Hematocrit * S. Amylase * BUN * S. lipase * S.Creatinine * S. Calcium * CRP * S. Triglycerides * LFT *S. Trypsin * Coagulation * Blood sugar profile
ENZYMES S.Amylase Normal values 23-85U/L Sources : parotids, pancreas, fallopian tube, sweat, Types : S-type and P-type ( isoenzymes ) Metabolism : renal & hepatic Half life : 7 to 14 hrs sensitive & Highly nonspecific
High Amylase levels seen in *Pancreatic disorders *Salivary disorders *Renal failure * Macroamylasemia *Intestinal diseases- gut infarction perforation , peritonitis,obstruction * Ruptured ectopic pregnancy * ectopic production : cancers of pancreas, thymus, breast, lung ,ovary. * DKA and other acidotic conditions
Amylase No corelation b/n severity of pancreatitis and degree of enzyme elevation Usually rises within 24hrs of attack and returns to normal within 48-72hrs After 3-7 days normalises even if inflammation continues. Hence normal levels doesn’t exclude the disease
Amylase – P more specific than serum Amylase
Low Amylase levels………….. May be seen in certain pancreatic cancers Toxaemia of pregnancy
Confirmed Pancreatitis with Normal Amylase levels….. Hypertriglyceridemia (high triglycerides interferes with enzyme assay) Some times in patients with Alcoholic pancreatitis
S.Lipase More specific (95%) Remains for longer time in serum than amylase Stays even upto 8to 14 days useful in patiets who are presenting lately Half life about 10to 14hrs Level of lipase can’t predict disease severity and outcome
High serum lipase levels seen in *Hollow viscus perforation *Intestinal obstruction *Intestinal ischemia In case of Alcoholic pancreatitis S. lipase is more elevated than S.Amylase
S.CALCIUM May be high or low Hypercalcemia – cause Hypocalcemia - effect of pancreatitis Low Calcium levels correlates with severity of disease <7mg/dl with normal albumin levels associated with tetany have poor prognosis
S. TRIGLYCERIDES High levels of >900-1000 mg/dl associated with increased risk Estimated in fasting states Usually asso . with Type I ,V Hyperlipidemias
Markers of Hemoconcentration *BUN > 22 mg/dl * Hematocrit atAdmission >44 %( highNPV ) * S.Creatinine at 48 hrs of Admission > 1.8mg/dl (high PPV) Helpful in assessing fluid status of patient Predictors of Pancreatic Necrosis
CRP Elevated CRP of >150 mg/dl at 48 hrs of admission suggestive of severe disease. single important prognostic indicator of severity LFT hyperbilirubinemia >4mg/dl may be seen in 10% patients assiciated with gall stone associated pancreatitis Elevated ALP also seen
IMAGING IN PANCREATITIS
ROLE OF PLAIN X-RAY
SIGNS Sentinal loop Colon cutoff sign Renal halo sign Loss of psoas shadow Gall stone may be seen Multiple calcifications in case of accute on chronic pancreatitis patient pleural effusion Lt> Rt
COLON CUTOFF SIGN
D/D for Colon Cut Off sign *Pancreatitis *IBD *Mesenteric ischemia *Carcinoma Colon
SENTINAL LOOP SIGN D/D
ROLE OF USG AND DOPPLER
Diffuse Decrease in Pancreatic Echogenicity (than liver) Free fluid Increased volume of Pancreas i.e , Bulky Pancreas (AP diameter >24mm) Gall stones Parenchymal inhomogenicty may correlate with necrosis Pseudocysts Spleenic vien thrombosis etc..
ROLE OF CT IN PANCREATITIS
MANAGEMENT
1.FLUID RECUSCITATION Main stay of therapy Initially 15-20ml/kg bolus administered Then f/b 3ml/kg/hr infusion should be kept to maintain urine output of >0.5cc/kg/hr Serial evaluations done to assess fluid status clinically and by measuring BUN & Hematocrit every 8-12 hrs.
Decrease in serial BUN & Hematocrit ensues adequate resuscitation Adjust fluid rates of infusion in patients with co morbid cardiac , pulmonary , renal illnesses Increasing BUN & Hematocrit inspite of aggressive fluid therapy can be treated with repeated volume challenge with 2L crystalloid bolus f/b increase in infusion rate by 1.5ml/kg/hr .
If still unresponsive transfer to intensive unit for careful hemodynamic monitering . Fluid of choice is Lactated Ringer which reduces systemic inflammation and preffered over Normal Saline
2. Pain Management Opiates like Buprenorphine is DOC Pethidine can be given alternatively Meperidine 100to 150mg IM can be given every 4 th hrly if necessary NSAID of choice is Metimazole Morphine is contraindicated.
3.NBM NPO is no longer advisable Usually kept for 2-3 days with ryles tube aspiration As soon as possible oral fluids are allowed even enzymes are elevated Initially with soft liquids Later with low fat diet preferred Maintains barrier integrity and decreases bacterial translocation
4. Role of Antibiotics Prophylactic therapy has no role Mild disease doesn’t needs antibiotics at all For severe pancreatitis i.e , with necrosis may benefit Definitive role is seen with proven cases of infected Necrosis Antibiotics of choice are CARBAPENUMS
IMIPENUM 5oomg 8 th hrly given Alternatively Cefuroxime 1.5g IV TID f/b 250mg oral BD for 14 days Meropenum and combination of Ciprofloxacin and Metronidazole doesn’t appear to reduce frequency of infected necrosis and MODS
5.Supportive therapy FFP transfusions in case of DIC Ionotropes for cardiac support Mechanical ventilation for ARDS Hemofilteration etc….
In Spl situations like…… 1. Gall stone pancreatitis : *should undergo ERCP within 24-48hrs of admission to prevent recurrence * cholecystectomy may be done on later date
2.Hypertriglyceridemia : *Initially treated with Insulin , Heparin, plasmapheresis * later hypolipidemic drugs like Fibrates , Niacin can be used. 3. ERCP induced Pancreatitis: *Rectal Indomethacin , Allopurinol , newer drug Ulinastatin , aggressive hydration with ringered lactate can prevent this .
NECROSIS May be sterile(60%) or infected(40%) Prophylactic antibiotics no role Infected necrosis can be suspected by clinical deterioration with persistant MODS Aspirated under CT guidance sent for gram’s and culture
Pseudocyst Emperical antibiotic therapy with Imipenum can be started Step up approach Requires 4wks for epithelisation and maturation Resolve spontaneously with in 6wks May or may not communicate with ductal system
SURGEON’S ROLE 1. Necrosis - necrosectomy *indications : worsening sepsis in case of infected necrosis 2.pseudocyst – >6cm lasting for 12 wks producing pressure symptoms warrants surgery
Prognosis Risk of chronic pancreatitis after an attack of accute alcoholic pancreatitis is 13% in 10 yrs & 16% in 20 yrs
Follow up care Aimed towards assessment of risk of DM Exocrine Pancreatic insufficiency etc..